Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal H G Duijf

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|June 9, 2020
Low baseline pulmonary levels of cytotoxic lymphocytes as a predisposing risk factor for severe COVID-19Pascal H G Duijf
Msystems|September 3, 2020
Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19Pascal H G Duijf
Molecular & Cellular Oncology|May 12, 2020
Complexities of pharmacogenomic interactions in cancerKum Kum Khanna, Pascal H G Duijf
International Journal of Cancer|November 6, 2012
Cancer cells preferentially lose small chromosomesPascal H G Duijf, Nikolaus Schultz, Robert Benezra
Cell Cycle (Georgetown, Tex.)|January 3, 2019
Mitotic slippage: an old tale with a new twistDebottam Sinha, Pascal H G Duijf, Kum Kum Khanna
Trends in Pharmacological Sciences|February 14, 2024
Targeting chromosomal instability and aneuploidy in cancerSugandha Bhatia, Kum Kum Khanna, Pascal H G Duijf
Targeted Oncology|March 30, 2016
Overexpression of Ran GTPase Components Regulating Nuclear Export, but not Mitotic Spindle Assembly, Marks Chromosome Instability and Poor Prognosis in Breast CancerSrividya Vaidyanathan, Pulari U Thangavelu, Pascal H G Duijf
Human Molecular Genetics|April 2, 2003
Pathogenesis of split-hand/split-foot malformationPascal H G Duijf, Hans van Bokhoven, Han G Brunner
Journal of Cellular Physiology|March 10, 2018
Treating cancer with microRNA replacement therapy: A literature reviewNayer Hosseinahli, Mahyar Aghapour, Pascal H G Duijf, et al.
Translational Oncology|January 30, 2021
Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancersDawn C Janysek, Jennifer Kim, Pascal H G Duijf, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|June 9, 2020
Low baseline pulmonary levels of cytotoxic lymphocytes as a predisposing risk factor for severe COVID-19Pascal H G Duijf
Msystems|September 3, 2020
Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19Pascal H G Duijf
Molecular & Cellular Oncology|May 12, 2020
Complexities of pharmacogenomic interactions in cancerKum Kum Khanna, Pascal H G Duijf
International Journal of Cancer|November 6, 2012
Cancer cells preferentially lose small chromosomesPascal H G Duijf, Nikolaus Schultz, Robert Benezra
Cell Cycle (Georgetown, Tex.)|January 3, 2019
Mitotic slippage: an old tale with a new twistDebottam Sinha, Pascal H G Duijf, Kum Kum Khanna
Trends in Pharmacological Sciences|February 14, 2024
Targeting chromosomal instability and aneuploidy in cancerSugandha Bhatia, Kum Kum Khanna, Pascal H G Duijf
Targeted Oncology|March 30, 2016
Overexpression of Ran GTPase Components Regulating Nuclear Export, but not Mitotic Spindle Assembly, Marks Chromosome Instability and Poor Prognosis in Breast CancerSrividya Vaidyanathan, Pulari U Thangavelu, Pascal H G Duijf
Human Molecular Genetics|April 2, 2003
Pathogenesis of split-hand/split-foot malformationPascal H G Duijf, Hans van Bokhoven, Han G Brunner
Journal of Cellular Physiology|March 10, 2018
Treating cancer with microRNA replacement therapy: A literature reviewNayer Hosseinahli, Mahyar Aghapour, Pascal H G Duijf, et al.
Translational Oncology|January 30, 2021
Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancersDawn C Janysek, Jennifer Kim, Pascal H G Duijf, et al.
Pageof 8